TrialJournal of neuro-oncology2019

Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.

Prakirthi Yerram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.